Elbonix (Eltrombopag) tablets contain Eltrombopag Olamine. It is a thrombopoietin receptor agonist which induces megakaryocyte proliferation and differentiation. As a result platelet counts increases in thrombocytopenic patients.

Elbonix is indicated for the treatment of:

  • Chronic Idiopathic Thrombocytopenic Purpura (ITP)
  • Severe Aplastic Anemia (SAA)
  • Thrombocytopenia in patients with Hepatitis C infection
  • Chemotherapy Induced Thrombocytopenia (CIT)